| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Carter Todd Alfred is a Chief Scientific Officer at Voyager Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $606K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 2,193 | $7.76 | $17,017.68 | -3.2% | +81.0% | +30.1% | |
| Feb 17, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 738 | $7.45 | $5,498.10 | -1.1% | +65.1% | +1.6% | |
| Feb 13, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 797 | $7.67 | $6,112.99 | -2.3% | +33.2% | -8.5% | |
| Jan 17, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,106 | $9.85 | $10,892.42 | -1.5% | -14.0% | -20.7% | |
| Jan 6, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 388 | $6.41 | $2,487.08 | -1.1% | +14.8% | +27.2% |